Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
Br J Psychiatry
; 217(3): 471-474, 2020 09.
Article
en En
| MEDLINE
| ID: mdl-32362299
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Ansiedad
/
Neumonía Viral
/
Psicoterapia
/
Psicotrópicos
/
Pautas de la Práctica en Medicina
/
Infecciones por Coronavirus
/
Pandemias
/
Trastornos Mentales
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Prognostic_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Br J Psychiatry
Año:
2020
Tipo del documento:
Article
País de afiliación:
Países Bajos